P01857 (IGHG1_HUMAN) Homo sapiens (Human)
Immunoglobulin heavy constant gamma 1 UniProtKBInterProInteractive Modelling
399 aa; Sequence (Fasta) ; (Isoform 1)
It is possible new templates exist for this target since these models were created.
Available Structures
172 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 … |
Heteromer P01834; | 99.69 | 1×NAG; 1×NAG; | |||
| Solution structure of human Immunoglobulin M |
Heteromer Q6PYX1; | 98.0 | ||||
| Structure of a membrane protein G |
Heteromer P11912; P40259; | 100 | ||||
| Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgIII… |
Heteromer P08637; | 100 | 2×NAG; 1×NAG; 1×NAG; 1×MLI; | |||
| Structure of FcgammaRI in complex with Fc reveals the importance of glycan recognition for high aff… |
Heteromer P12314; | 100 | 2×NAG; | |||
| Crystal structure of nonfucosylated Fc complexed with bis-glycosylated soluble form of Fc gamma rec… |
Heteromer P08637; | 100 | 2×NAG; 1×NAG; 1×NAG; | |||
| CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX |
Heteromer O75015; | 96.76 | 1×NAG; 1×NAG; | |||
| The complex structure between human IgG1 Fc and its high affinity receptor FcgRI H174R variant |
Heteromer P12314; | 100 | 2×NAG; 3×NA; | |||
| The complex structure between human IgG1 Fc and its high affinity receptor FcgRI H174R variant |
Heteromer P12314; | 100 | 1×NAG; 1×NAG; 2×SO4; | |||
| The complex structure between human IgG1 Fc and its high affinity receptor FcgRI H174R variant |
Heteromer P12314; | 100 | 2×NAG; 1×MG; | |||
| Crystal structure of nonfucosylated Fc Y296W mutant complexed with bis-glycosylated soluble form of… |
Heteromer P08637; | 99.53 | 1×NAG; 1×NAG; 1×NAG; 1×NAG; 1×CL; | |||
| High-resolution crystal structure of Fc bound to its human receptor Fc-gamma-RI |
Heteromer P12314; | 99.53 | 2×NAG; 1×NAG; 1×NAG; 6×ZN; 9×ACT; 2×GOL; | |||
| IgG1 Fc-FcgammaRI ecd complex |
Heteromer P12314; | 100 | 1×NAG; 1×NAG; 1×NAG; 2×NAG; 2×NAG; 3×ZN; | |||
| CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEX… |
Heteromer O75015; | 99.05 | 1×NAG; 1×NAG; | |||
| Complex of fcgammariia (CD32) and the FC of human IGG1 |
Heteromer P12318; | 96.73 | 1×NDG; 1×NAG; 1×NDG; 4×GOL; 1×NAG; | |||
| Unique carbohydrate/carbohydrate interactions are required for high affinity binding of FcgIII and … |
Heteromer P08637; | 100 | 2×NAG; 1×NAG; 1×NAG; 1×MLI; | |||
| Crystal structure of IIb selective Fc variant, Fc(V12), in complex with FcgRIIb |
Heteromer P31995; | 97.17 | 1×NAG; 1×NAG; 1×NAG; | |||
| CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORT… |
Heteromer O75015; | 99.05 | 1×NAG; 1×NAG; 1×HG2; | |||
| Crystal structure of IIb selective Fc variant, Fc(P238D), in complex with FcgRIIb |
Heteromer P31994; | 99.53 | 2×NAG; | |||
| Crystal structure of asymmetrically engineered Fc variant in complex with FcgRIIIa |
Heteromer P08637; | 96.23 | 2×NAG; 1×NAG; 1×NAG; 7×IOD; | |||
| IgG Fc bound to 3 helix of the B-domain from Protein A |
Heteromer P02976; | 99.03 | 1×NAG; 1×NAG; | |||
| G-2 glycovariant of human IgG Fc bound to minimized version of Protein A called Z34C |
Heteromer | 100 | 1×NAG; 1×NAG; | |||
| Knob-into-hole IgG Fc |
Heteromer | 97.62 | ||||
| Crystal structure of the artificial protein AFFinger p17 (AF.p17) complexed with Fc fragment of hum… |
Heteromer | 100 | 2×NAG; | |||
| Crystal Structure of an Autoimmune Complex between a Human IgM Rheumatoid Factor and IgG1 Fc reveal… |
Heteromer | 99.52 | 2×NAG; 1×CD; 2×ZN; 1×CAC; 6×MPD; 4×ACT; | |||
| Complex between G0 version of an Fc bound to a minimized version of Protein A called Mini-Z |
Heteromer | 100 | 1×NAG; 1×NAG; | |||
| Crystal structure of GASDALIE IgG1 Fc in complex with FcgRIIIa |
Heteromer P08637; | 98.09 | 1×NAG; 1×NAG; 1×FUC; 2×NAG; | |||
| Crystal structure of FcRn and beta-2-microglobulin in complex with IgG1-Fc-MST-HN (efgartigimod) |
Heteromer P55899; P61769; | 97.61 | 1×NAG; 1×NAG; | |||
| Ternary complex between Neonatal Fc receptor, serum albumin and Fc |
Heteromer P02768; P55899; P61769; | 98.56 | 2×NAG; | |||
| GLYCOSYLATED KNOB/DUMMY-HOLE FC FRAGMENT |
Heteromer P0DOX5; | 99.11 | 2×NAG; | |||
| 2 helix minimized version of the B-domain from Protein A (Z34C0 bound to IgG1 Fc (monoclinic form) |
Heteromer | 99.03 | 2×NAG; | |||
| BEAT Fc |
Heteromer P01860; | 100 | 2×NAG; | |||
| Crystal structure of extracellular domain of HER2 in complex with Fcab STAB19 |
Heteromer P04626; | 95.19 | 2×NAG; 2×NAG; 2×GOL; 4×NAG; | |||
| FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C |
Heteromer | 100 | 1×NAG; | |||
| Stable Effector Functionless 2 (SEFL2) IgG1 Fc Scaffold Bound to a Minimized Version of the B-domai… |
Heteromer | 97.58 | ||||
| COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC |
Heteromer P19474; | 100 | 2×NAG; 2×FUC; | |||
| Crystallographic Refinement and Atomic Models of a Human FC Fragment and its Complex with Fragment … |
Heteromer P38507; | 96.62 | 2×NAG; 2×SO4; | |||
| Crystal structure of extracellular domain of HER2 in complex with Fcab H10-03-6 |
Heteromer P04626; | 95.17 | ||||
| Crystal Structure of a gE-gI/Fc complex |
Heteromer P04488; | 99.03 | 2×NAG; | |||
| CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HU… |
Heteromer P19909; | 96.6 | ||||
| Anti-beta-amyloid antibody c706 fab in space group P21 |
Heteromer | 97.2 | ||||
| Crystal structure of the anti-human NGF Fab APE1531 |
Heteromer Q8TCD0; | 94.23 | 2×MES; 4×ACT; 1×PGE; | |||
| Crystal structure of human anti-tau antibody CBTAU-27.1 |
Heteromer P01834; | 98.08 | 2×GOL; | |||
| Crystal structure of NIH45-46 Fab |
Heteromer P01834; | 99.04 | 3×GOL; 1×SO4; 1×NAG; | |||
| Crystal structure of APE1551, an anti-human NGF Fab with a nine amino acid insertion in CDR H1 |
Heteromer Q8TCD0; | 94.17 | ||||
| Crystal structure of broad and potent HIV-1 neutralizing antibody PGT127 in complex with Man9 |
Heteromer | 98.96 | 1×MAN; 1×AML; | |||
| THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR TETANUS TOXOID |
Heteromer P0DOY2; | 99.03 | ||||
| 48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID |
Heteromer P01834; | 100 | 1×NPE; | |||
| TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY |
Heteromer | 100 | ||||
| IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY |
Heteromer | 100 | ||||
| IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PE… |
Heteromer | 100 | 1×NPE; | |||
| ANTIBODY GNC92H2 BOUND TO LIGAND |
Heteromer P01834; | 100 | 1×COC; | |||
| Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D |
Heteromer P00746; P01834; | 100 | ||||
| FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY |
Heteromer P01834; | 100 | ||||
| STRUCTURE OF A HUMAN MONOCLONAL ANTIBODY FAB FRAGMENT AGAINST GP41 OF HUMAN IMMUNODEFICIENCY VIRUS … |
Heteromer P01834; | 100 | ||||
| Anti-beta-amyloid antibody c706 fab in space group c2 |
Heteromer P01834; | 100.0 | ||||
| Crystal structure of broadly and potently neutralizing antibody VRC08 in complex with HIV-1 clade A… |
Heteromer P01834; Q8JDI3; | 100.0 | 11×NAG; 2×BU3; | |||
| Germline 7G12 with N-methylmesoporphyrin |
Heteromer | 100 | 1×MMP; | |||
| Crystal structure of IL-23 in complex with neutralizing FAB |
Heteromer P29460; Q9NPF7; | 100.0 | 1×IMD; 2×MPD; | |||
| Crystal structure of broadly and potently neutralizing antibody VRC08C in complex with HIV-1 clade … |
Heteromer P01834; Q8JDI3; | 100 | 11×NAG; | |||
| Crystal structure of 10E8-S74W Fab in complex with an HIV-1 gp41 peptide. |
Heteromer V9QIE5; | 100 | ||||
| Crystal structure of broad and potent HIV-1 neutralizing antibody PGT128 in complex with Man9 |
Heteromer | 98.99 | 1×MAN; 4×GOL; 1×AML; 1×EPE; | |||
| Structure of redesigned IgG1 first constant and lambda domains (CH1:Clambda constant redesign 2 bet… |
Heteromer P0DOY2; | 98.99 | 1×PG6; | |||
| Structure of redesigned IgG1 first constant and lambda domains (CH1:Clambda constant redesign 1, CR… |
Heteromer P0DOY2; | 97.03 | ||||
| Crystal structure of a disease-associated anti-human GM-CSF autoantibody MB007 |
Heteromer P0DOY2; | 99.01 | ||||
| CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION |
Heteromer P01834; | 100 | 4×CD; 1×HOP; | |||
| UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY |
Heteromer P01834; | 100 | 3×CD; | |||
| Crystal structure of human anti-tau antibody CBTAU-27.1 Fab in complex with a human tau peptide |
Heteromer A0A2K5IAM2; P01834; | 99.01 | ||||
| Crystal structure of a humanised 3D6 Fab bound to amyloid beta peptide |
Heteromer P01834; P05067; | 99.01 | ||||
| Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D |
Heteromer F6YBP7; Q8TCD0; | 100 | 3×GOL; 4×ZN; 2×SO4; | |||
| Crystal structure of 10E8v4 Fab in complex with an HIV-1 gp41 peptide. |
Heteromer Q1HSF8; | 100.0 | ||||
| Structure of NIH45-46 Fab in complex with gp120 of 93TH057 HIV |
Heteromer A0A0M3KKW9; P01834; | 98.97 | 1×NAG; 1×FLC; 6×NAG; 1×CL; | |||
| MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN |
Heteromer Q7Z3Y4; | 100 | 5×CD; 1×HOP; | |||
| UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY |
Heteromer P01834; | 100 | 1×CD; | |||
| Crystal structure of broad and potent HIV-1 neutralizing antibody PGT128 in complex with a glycosyl… |
Heteromer P04578; P0DOY2; Q75760; | 98.99 | 1×NAG; 1×NAG; | |||
| Crystal structure of broadly and potently neutralizing antibody VRC06B in complex with HIV-1 clade … |
Heteromer P01834; Q0ED31; | 100.0 | 1×NAG; 6×NAG; | |||
| Crystal structure BG505 SOSIP gp140 HIV-1 Env trimer bound to broadly neutralizing antibodies PGT12… |
Heteromer P01834; Q2N0S6; S6B291; | 100.0 | 12×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; 3×NAG; 3×NAG; 18×NAG; 3×SO4; | |||
| AD related murine antibody Fragment |
Heteromer P01647; P01808; P01834; | 100.0 | ||||
| Crystal Structure of mid-region amyloid beta capture by solanezumab |
Heteromer P01834; P05067; | 100.0 | ||||
| Murine 6A6 Fab in complex with humanized anti-Tissue Factor D3H44 Fab |
Heteromer G0YP42; P01863; Q7Z3Y4; | 100.0 | ||||
| Crystal Structure at 4.3 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env T… |
Heteromer P04578; P0DOY2; Q2N0S6; | 98.65 | 6×NAG; 3×NAG; 3×NAG; 24×NAG; 3×NAG; 3×NAG; 3×NAG; 18×NAG; 3×SO4; | |||
| Structure of wild-type IgG1 antibody heavy chain constant domain 1 and light chain lambda constant … |
Heteromer P0DOY2; | 100 | ||||
| Structure of the Human Metapneumovirus Fusion Protein with Neutralizing Antibody Identifies a Pneum… |
Heteromer G3KCK8; Q8N5F4; | 97.96 | 2×NAG; | |||
| BEAT Fc with improved heterodimerization (Q3A-D84.4Q) |
Heteromer P01860; P0DOX5; | 100 | 2×NAG; | |||
| Crystal structure of the anti-hinge rabbit antibody 2095-2 in complex with IDES hinge peptide |
Heteromer | 100 | 5×GOL; | |||
| Crystal structure of the QAA variant of anti-hinge rabbit antibody 2095-2 in complex with IDES hing… |
Heteromer | 100 | ||||
| Crystal structure of a human IgG1 Fc-fragment,high salt condition | homo-4-mer | 96.62 | 2×NAG; 2×NAG; | |||
| Crystal structure of IgG1-Fc-MST-HN (efgartigimod) | homo-3-mer | 97.62 | 2×NAG; 1×NAG; 2×MAN; 1×NAG; 4×NAG; 1×BMA; 2×MAN; 1×FUC; | |||
| Engineered human IgG Fc domain glyco801 (Fc801) | homo-2-mer | 99.08 | 1×NAG; 1×K; 2×MAN; 1×NAG; | |||
| F241A Fc | homo-2-mer | 99.53 | 1×NAG; 1×NAG; | |||
| Fc K392D/K409D homodimer | homo-2-mer | 99.02 | 2×SO4; | |||
| Crystal Structure of the Fucosylated Fc Fragment from Human Immunoglobulin G1 | homo-2-mer | 100 | 2×NAG; 1×ZN; | |||
| Crystal Structure of the Defucosylated Fc Fragment from Human Immunoglobulin G1 | homo-2-mer | 100 | 1×NAG; 1×NAG; | |||
| Heterodimeric Fc Antibody Azymetric Variant 1 | homo-2-mer | 98.28 | 1×NAG; 1×NAG; 1×MAN; 1×NAG; 9×EDO; 3×IOD; | |||
| Heterodimeric Fc Antibody Azymetric Variant 2 | homo-2-mer | 98.28 | 2×NAG; 5×EDO; 3×IOD; | |||
| Fc fragment of IgG1 (Herceptin) with protein-A mimetic peptide dendrimer ligand. | homo-2-mer | 100 | 2×NAG; 1×X12; | |||
| Structural Characterization of a Human Fc Fragment Engineered for Lack of Effector Functions | homo-2-mer | 98.57 | 2×NAG; 8×ZN; | |||
| Human 1gG1 Fc fragment, 2.5 Angstrom structure | homo-2-mer | 99.04 | 2×NAG; | |||
| Crystal structure of VEGF binding IgG1-Fc (Fcab CT6) | homo-2-mer | 91.43 | 1×NAG; 1×NAG; | |||
| Crystal structure of monoclonal human anti-rhesus D Fc and IgG1 t125(yb2/0) in the presence of EDTA | homo-2-mer | 100 | 2×NAG; 2×GOL; | |||
| Crystal structure of monoclonal human anti-rhesus D Fc IgG1 t125(yb2/0) double mutant (H310 and H43… | homo-2-mer | 99.05 | 1×MAN; 7×NAG; 3×GOL; 5×MAN; 2×GAL; | |||
| Enzyme deglycosylated Human IgG1 Fc fragment | homo-2-mer | 98.56 | ||||
| Glycosylated, disulfide-linked Hole-Hole Fc fragment | homo-2-mer | 98.09 | 2×NAG; | |||
| Glycosylated Knob-Knob Fc fragment (P6122) | homo-2-mer | 99.04 | 2×NAG; | |||
| Fc Heterodimer Design 7.8 D399M/Y407A + T366V/K409V | homo-2-mer | 98.09 | 1×NAG; | |||
| human IgG1 Fc fragment Heterodimer | homo-2-mer | 100 | 2×NAG; | |||
| Crystal structure of monoclonal human anti-Rhesus D Fc IgG1 T125(YB2/0) in the presence of Zn2+ | homo-2-mer | 100 | 2×NAG; 6×ZN; 6×IMD; 2×GOL; | |||
| Crystal structure of sialylated IgG Fc | homo-2-mer | 99.03 | 1×NAG; 1×NAG; 2×CL; | |||
| Engineered human IgG Fc domain aglyco801 | homo-2-mer | 98.56 | ||||
| anti-CD20 monoclonal antibody Fc fragment | homo-2-mer | 99.04 | 2×NAG; | |||
| Wild type Fc (wtFc) | homo-2-mer | 100 | 2×NAG; | |||
| Crystal structure of a human Fc fragment engineered for extended serum half-life | homo-2-mer | 98.56 | 2×NAG; | |||
| Crystal Structure of an IgG1 Fc Glycoform (Man9GlcNAc2) | homo-2-mer | 99.52 | 1×NAG; 1×NAG; | |||
| Structural Characterization of a Mutated, ADCC-Enhanced Human Fc Fragment | homo-2-mer | 97.61 | 2×NAG; 8×ZN; | |||
| Crystal structure of a chemoenzymatic glycoengineered disialylated Fc (di-sFc) | homo-2-mer | 100 | 1×NAG; 1×NAG; | |||
| Crystal structure of human IgG1-Fc | homo-2-mer | 100 | 1×NAG; 1×NAG; 2×PO4; 3×GOL; | |||
| Crystal structure of IgG Fc with a homogeneous glycoform and Antibody-Dependent Cellular Cytotoxici… | homo-2-mer | 100 | 2×NAG; | |||
| Glycosylated Knob-Knob Fc fragment (P212121) | homo-2-mer | 99.04 | 2×NAG; | |||
| Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation H435A | homo-2-mer | 99.52 | 2×NAG; 2×EDO; | |||
| Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc (wild-type) | homo-2-mer | 100 | 2×NAG; 3×EDO; | |||
| Role of the hinge and C-gamma-2/C-gamma-3 interface in immunoglobin G1 Fc domain motions: implicati… | homo-2-mer | 100 | 1×NAG; 1×NAG; 1×PG4; | |||
| Fc Design 20.8.37 A chain homodimer Y349S/T366M/K370Y/K409V | homo-2-mer | 97.11 | ||||
| Fc Knob-Hole Heterodimer T366W + T366S/L368A/Y407V | homo-2-mer | 98.56 | 2×NAG; | |||
| Fc Heterodimer Design 6.1 F405W/Y407A + T366M | homo-2-mer | 98.08 | 2×NAG; | |||
| anti-CD20 monoclonal antibody Fc fragment | homo-2-mer | 99.04 | 2×NAG; 6×SO4; 4×ACT; | |||
| anti-parallel Fc-hole(T366S/L368A/Y407V) homodimer | homo-2-mer | 97.6 | ||||
| Crystal structure of a human IgG-aptamer complex | homo-2-mer | 100.0 | 1×MAN; 1×NDG; 2×CA; | |||
| Fc Heterodimer Design 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A | homo-2-mer | 97.11 | 2×NAG; | |||
| Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation N434A | homo-2-mer | 99.52 | 2×NAG; 2×EDO; | |||
| Fc Heterodimer Design 2.9 L368M/K370E + E357A/S364G | homo-2-mer | 98.08 | 2×NAG; | |||
| Fc Heterodimer Design 11.2 Y349S/K370Y + E357D/S364Q | homo-2-mer | 98.08 | 2×NAG; | |||
| Crystallographic structure of the Human Igg1 alpha 2-6 sialilated Fc-Fragment | homo-2-mer | 100 | 1×NAG; 1×NAG; | |||
| Fc Heterodimer Design 5.1 T366V + Y407F | homo-2-mer | 98.56 | 2×NAG; | |||
| Crystal Structure of Human IgG Fc Bearing Hybrid-type Glycans | homo-2-mer | 99.52 | 1×NAG; 1×CL; | |||
| Crystal structure of GASDALIE IgG1 Fc | homo-2-mer | 98.56 | 2×NAG; 1×FUC; | |||
| CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2 | homo-2-mer | 96.64 | 1×NAG; 1×NAG; | |||
| Crystal structure of the human igg1 fc-fragment,glycoform (mn2f)2 | homo-2-mer | 96.64 | 1×NAG; 1×BMA; | |||
| Fc Heterodimer Design 7.7 D399M/Y407A + T366V/K409I | homo-2-mer | 98.08 | 2×NAG; | |||
| Crystal structure of VEGF binding IgG1-Fc (Fcab 448) | homo-2-mer | 93.75 | 1×NAG; 1×NAG; 3×GOL; 1×MES; | |||
| CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2 | homo-2-mer | 96.64 | 2×NAG; | |||
| Deactivation of human IgG1 Fc by endoglycosidase treatment | homo-2-mer | 99.5 | 1×NAG; | |||
| Immunoglobulin Fc heterodimers variant | homo-2-mer | 98.56 | 2×NAG; | |||
| Immunoglobulin Fc heterodimer variant | homo-2-mer | 99.04 | 2×NAG; | |||
| anti-parallel Fc-knob (T366W) homodimer | homo-2-mer | 98.56 | 2×SO4; | |||
| Fc K392D/K409D homodimer | homo-2-mer | 98.08 | ||||
| Fc Heterodimer Design 7.4 Y407A + T366V/K409V | homo-2-mer | 98.56 | 2×NAG; | |||
| Fc Design 7.7 B chain homodimer T366V/K409I | homo-2-mer | 98.08 | ||||
| Fc Heterodimer E356K/D399K + K392D/K409D | homo-2-mer | 98.55 | 2×NAG; | |||
| Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation I253A/H310A | homo-2-mer | 99.04 | 1×NAG; 1×NAG; 1×NAG; | |||
| Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation I253A | homo-2-mer | 99.52 | 2×NAG; | |||
| Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation H310A | homo-2-mer | 99.52 | 2×NAG; 3×EDO; | |||
| Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation Y436A | homo-2-mer | 99.52 | 1×NAG; 1×NAG; 1×BMA; | |||
| Fc Heterodimer Design 9.1 Y407M + T366I | homo-2-mer | 98.56 | 2×NAG; | |||
| CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121 | homo-2-mer | 96.64 | 1×NAG; 1×NAG; | |||
| Aglycosylated human igg1 fc fragment | homo-2-mer | 100 | ||||
| Crystal structure of HER2 binding IgG1-Fc (Fcab STAB19) | homo-2-mer | 95.17 | 1×NAG; 1×NAG; | |||
| Modified single helix from the B-domain of protein A bound to IgG1 Fc | homo-2-mer | 99.03 | 2×NAG; | |||
| Crystal structure of human Fc at 1.80 A | homo-2-mer | 100 | 1×NAG; 1×NAG; 1×GOL; | |||
| Crystal structure of HER2 binding IgG1-Fc (Fcab H10-03-6) | homo-2-mer | 97.02 | 1×NAG; 1×NAG; | |||
| Fc Heterodimer Design 8.1 L368V/Y407A + T366V/K409F | homo-2-mer | 98.07 | 2×NAG; | |||
| Glycosylated, disulfide-linked Knob-into-Hole Fc fragment | homo-2-mer | 99.03 | 1×NAG; 1×NAG; | |||
| Structure of a Fc heterodimer | homo-2-mer | 97.4 | 1×NAG; 1×NAG; | |||
| FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2 | homo-2-mer | 98.55 | 1×NAG; 1×NAG; | |||
| Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation S254A | homo-2-mer | 99.51 | 2×NAG; 3×EDO; | |||
| CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT … | homo-2-mer | 96.62 | 2×NAG; | |||
| Fc Design 20.8.37 B chain homodimer E357D/S364R/Y407A | homo-2-mer | 97.58 | ||||
| Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and stru… | homo-2-mer | 96.6 | 2×NAG; | |||
| 1.52 Angstrom Crystal Structure of Fc fragment of Human IgG1. | homo-2-mer | 100 | 2×PGE; | |||
| monomeric Fc | monomer | 97.61 | 1×NAG; 1×NAG; | |||
| Structure of a Fc mutant | monomer | 99.04 | 1×NAG; | |||
| Crystal Structure of IgG Fc F241A mutant with native glycosylation | monomer | 98.55 | 1×NAG; 1×CL; | |||
| Crystal Structure of an isolated, unglycosylated antibody CH2 domain | monomer | 100 | ||||
4 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5w38.1.A | homo-2-mer | 0.85 | 94.09 | |||
| 6gfe.1.B | monomer | 0.81 | 91.93 | |||
| 6gfe.1.A | monomer | 0.81 | 91.93 | |||
| 6hyg.1.A | monomer | 0.76 | 1×ZN; | 72.00 | ||
4 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 1 | 5w38.1.A | homo-2-mer | 0.86 | 94.14 | |||
| Isoform 1 | 6gfe.1.A | monomer | 0.82 | 91.13 | |||
| Isoform 1 | 6gfe.1.B | monomer | 0.81 | 91.13 | |||
| Isoform 1 | 6hyg.1.A | monomer | 0.77 | 1×ZN; | 74.69 | ||